Business
Why the ResApp (ASX:RAP) share price is climbing higher
The ResApp Health Ltd (ASX: RAP) share price is climbing higher today. This comes after the company provided an update of its prescription-only software application with the United States Food and Drug Administration (FDA).
At the time of writing, shares in the digital health company are trading 1.4% higher at 6.8 cents.
What did ResApp announce?
In today’s release, ResApp advised it has sent a pre-submission package to the FDA for clearance on its smartphone-based medical software application. The company also requested a meeting with the FDA to discuss how to obtain regulatory approval and any other requirements.
ResApp’s latest software application uses machine-learning algorithms to detect cough sounds recorded by a…
-
Noosa News17 hours agoKarenia cristata species source of toxins in SA’s algal bloom, scientists believe
-
Noosa News10 hours agoExperts share tiny home warning as interest from young people soars
-
Noosa News10 hours agoExpert’s warning as tourists stunned by hundreds of sharks spotted close to shore at Moreton Island, Queensland
-
General10 hours agoDemocrats sweep first major test of Trump’s second term